Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion

被引:86
作者
Booden, MA
Eckert, LB
Der, CJ [1 ]
Trejo, J
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Cardiovasc Biol Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1128/MCB.24.5.1990-1999.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased expression of protease-activated receptor 1 (PAR1), a G protein-coupled receptor for thrombin, has previously been correlated with breast carcinoma cell invasion. PAR1 is irreversibly proteolytically activated, internalized, and sorted directly to lysosomes, a critical process for the termination of signaling. We determined that activated PAR1 trafficking is severely altered in metastatic breast carcinoma cells but not in nonmetastatic or normal breast epithelial cells. Consequently, the proteolytically activated receptor is not sorted to lysosomes and degraded. Altered trafficking of proteolytically activated PAR1 caused sustained activation of phosphoinositide hydrolysis and extracellular signal-regulated kinase signaling, even after thrombin withdrawal, and enhanced cellular invasion. Thus, our results reveal that a novel alteration in trafficking of activated PAR1 causes persistent signaling and, in addition to other processes and proteins, contributes to breast carcinoma cell invasion.
引用
收藏
页码:1990 / 1999
页数:10
相关论文
共 39 条
[11]   Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the αvβ5 integrin [J].
Even-Ram, SC ;
Maoz, M ;
Pokroy, E ;
Reich, R ;
Katz, BZ ;
Gutwein, P ;
Altevogt, P ;
Bar-Shavit, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10952-10962
[12]  
Gilhooly EM, 1999, INT J ONCOL, V15, P267
[13]   Role of thrombin receptor in breast cancer invasiveness [J].
Henrikson, KP ;
Salazar, SL ;
Fenton, JW ;
Pentecost, BT .
BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :401-406
[14]   CLONED PLATELET THROMBIN RECEPTOR IS NECESSARY FOR THROMBIN-INDUCED PLATELET ACTIVATION [J].
HUNG, DT ;
VU, TKH ;
WHEATON, VI ;
ISHII, K ;
COUGHLIN, SR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1350-1353
[15]  
ISHII K, 1994, J BIOL CHEM, V269, P1125
[16]  
KAHAN C, 1992, J BIOL CHEM, V267, P13369
[17]   Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin [J].
Kahn, ML ;
Nakanishi-Matsui, M ;
Shapiro, MJ ;
Ishihara, H ;
Coughlin, SR .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :879-887
[18]   G-protein-coupled receptors and signaling networks: emerging paradigms [J].
Marinissen, MJ ;
Gutkind, JS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (07) :368-376
[19]   The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways [J].
Martin, CB ;
Mahon, GM ;
Klinger, MB ;
Kay, RJ ;
Symons, M ;
Der, CJ ;
Whitehead, IP .
ONCOGENE, 2001, 20 (16) :1953-1963
[20]   Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis [J].
Mueller, BM ;
Ruf, W .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1372-1378